Leadership, Planning and Evaluation
Leadership, Planning and Evaluation
批准号:
10675627
负责人:
David A Tuveson
金额:
$27.01万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-08-01 至 2026-07-31
关键词:
AddressAppointmentAreaBasic Cancer ResearchCancer CenterCancer Center Support GrantCommunicationDevelopmentEducationEnsureEvaluationFundingFutureGene Expression RegulationGoalsGrantHealthHuman BiologyLaboratoriesLeadershipMalignant NeoplasmsMethodsNCI Center for Cancer ResearchPositioning AttributeRecording of previous eventsResearchResearch PersonnelResource SharingServicesStrategic visionTechnologyTrainingTranslational ResearchVisionWorkanticancer researchcancer research center directordesignflexibilityimprovedinnovationmemberoperationpre-clinicalprogramsrecruit
中文摘要
领导、规划和评价--项目摘要/摘要
冷泉港实验室(CSHL)癌症中心由David Tuveson主任(细胞
癌症传播计划)。图弗森接替前癌症中心主任布鲁斯·斯蒂尔曼成为
2016年担任癌症中心主任。作为局长,图文森负责总体方向,规划,
以及分配癌症中心发展和可自由支配的资金,以支持他对CSHL的愿景
癌症中心,包括对癌症研究和共享资源的支持。他得到了四名副手的协助
导演:禤浩焯·克雷纳(基因调控与遗传计划),尼古拉斯·唐克斯(细胞
癌症中的通讯计划)、劳埃德·特罗特曼(癌症中的细胞通讯计划)和丹尼斯
罗伯茨(行政)克雷纳,项目副主任,主要负责监督癌症
中心计划,以确保它们与癌症中心的战略愿景保持一致,并确定
会员资助金与癌症的相关性。运营副总监Tonks主要负责监督
共享资源的管理,以确保它们维持卓越的服务和科学支持。特罗特曼,副手
教育和多样性主任,监督癌症中心教育倡议,为癌症中心提供建议
负责招聘,并协调癌症中心的教育活动和T32癌症培训基金的活动。
行政副署长罗伯茨代表癌症协调所有行政服务
负责并协助Tonks管理共享资源。Tuveson已经对
CSHL癌症中心,包括任命新的领导,癌症的重组和品牌重塑
中心计划,招募新成员,建立新的共享资源,推出新的
教育倡议,并加强癌症中心和诺斯韦尔健康之间的联盟,以
促进翻译研究。规划和评估是确保癌症中心保持其
高度创新的研究和一流的共享资源。在癌症中心高层领导的帮助下
和癌症中心执行委员会,主任制定了一个明确而灵活的愿景
即将到来的拨款周期。内部和外部委员会,包括外部咨询委员会的咨询意见,
被癌症中心领导层用来评估计划并确保战略计划设计良好
并得到有效实施。CSHL癌症中心领导层致力于维护和继续
完善癌症中心,确保其作为基础癌症研究的首选机构的地位。
英文摘要
LEADERSHIP, PLANNING AND EVALUATION – PROJECT SUMMARY/ABSTRACT
The Cold Spring Harbor Laboratory (CSHL) Cancer Center is led by Director David Tuveson (Cellular
Communication in Cancer Program). Tuveson succeeded former Cancer Center Director Bruce Stillman as the
Director of the Cancer Center in 2016. As Director, Tuveson is responsible for the overall direction, planning,
and allocation of Cancer Center Developmental and discretionary funds to support his vision for the CSHL
Cancer Center, including support of cancer research and the Shared Resources. He is assisted by four Deputy
Directors: Adrian Krainer (Gene Regulation and Inheritance Program), Nicholas Tonks (Cellular
Communication in Cancer Program), Lloyd Trotman (Cellular Communication in Cancer Program), and Denise
Roberts (Administration). Krainer, Deputy Director of Programs, is primarily responsible for oversight of Cancer
Center Programs to ensure they align with the strategic vision for the Cancer Center, and for determining the
cancer relevance of members’ grants. Tonks, Deputy Director of Operations, is primarily responsible for oversight
of the Shared Resources to ensure they maintain exceptional services and scientific support. Trotman, Deputy
Director of Education and Diversity, oversees Cancer Center educational initiatives, advises in Cancer Center
recruitment, and coordinates Cancer Center educational initiatives with those of the T32 Cancer Training Grant.
Roberts, Deputy Director of Administration, coordinates all administrative services on behalf of the Cancer
Center and aids Tonks in the management of Shared Resources. Tuveson has instituted several changes to the
CSHL Cancer Center, including the appointment of new Leadership, reorganization and rebranding of Cancer
Center Programs, recruitment of new members, establishing new Share Resources, launching of new
educational initiatives, and strengthening the alliance between the Cancer Center and Northwell Health to
promote translational research. Planning and evaluation are critical to ensure the Cancer Center maintains its
highly innovative research and first-rate Shared Resources. With the help of Cancer Center Senior Leadership
and the Cancer Center Executive Committee, the Director has developed a clear, yet flexible, vision for the
coming grant cycle. Advice from both internal and external committees, including the External Advisory Board,
is used by the Cancer Center Leadership to evaluate plans and ensure that strategic initiatives are well designed
and effectively implemented. The CSHL Cancer Center Leadership are committed to maintaining and continually
improving the Cancer Center to ensure its position as a premiere institute for basic cancer research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fibroblast Heterogeneity in Pancreatic Cancer
-
批准号:10675741
-
项目类别:
-
资助金额:$78.02万
-
财政年份:2021
-
负责人:David A Tuveson
-
依托单位:
Fibroblast Heterogeneity in Pancreatic Cancer
-
批准号:10299050
-
项目类别:
-
资助金额:$81.89万
-
财政年份:2021
-
负责人:David A Tuveson
-
依托单位:
Fibroblast Heterogeneity in Pancreatic Cancer
-
批准号:10467049
-
项目类别:
-
资助金额:$78.0万
-
财政年份:2021
-
负责人:David A Tuveson
-
依托单位:
Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response
-
批准号:10056198
-
项目类别:
-
资助金额:$61.57万
-
财政年份:2016
-
负责人:David A Tuveson
-
依托单位:
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
-
批准号:9122093
-
项目类别:
-
资助金额:$56.05万
-
财政年份:2014
-
负责人:David A Tuveson
-
依托单位:
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
-
批准号:9336271
-
项目类别:
-
资助金额:$55.27万
-
财政年份:2014
-
负责人:David A Tuveson
-
依托单位:
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
-
批准号:8792084
-
项目类别:
-
资助金额:$55.57万
-
财政年份:2014
-
负责人:David A Tuveson
-
依托单位:
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
-
批准号:8930940
-
项目类别:
-
资助金额:$55.57万
-
财政年份:2014
-
负责人:David A Tuveson
-
依托单位:
Mutant mouse models of exocrine pancreatic cancer
-
批准号:7498542
-
项目类别:
-
资助金额:$20.99万
-
财政年份:2004
-
负责人:David A Tuveson
-
依托单位:
Mutant mouse models of exocrine pancreatic cancer
-
批准号:6916463
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2004
-
负责人:David A Tuveson
-
依托单位:
Mutant mouse models of exocrine pancreatic cancer
-
批准号:7227182
-
项目类别:
-
资助金额:$20.99万
-
财政年份:2004
-
负责人:David A Tuveson
-
依托单位:
Mutant mouse models of exocrine pancreatic cancer
-
批准号:7084399
-
项目类别:
-
资助金额:$29.87万
-
财政年份:2004
-
负责人:David A Tuveson
-
依托单位:
Mutant mouse models of exocrine pancreatic cancer
-
批准号:6829313
-
项目类别:
-
资助金额:$31.91万
-
财政年份:2004
-
负责人:David A Tuveson
-
依托单位:
CSHL Cancer Center Support Grant
-
批准号:9975703
-
项目类别:
-
资助金额:$440.4万
-
财政年份:1997
-
负责人:David A Tuveson
-
依托单位:
CSHL Cancer Center Support Grant
-
批准号:9321024
-
项目类别:
-
资助金额:$439.54万
-
财政年份:1997
-
负责人:David A Tuveson
-
依托单位:
Administration
-
批准号:10675614
-
项目类别:
-
资助金额:$20.44万
-
财政年份:1997
-
负责人:David A Tuveson
-
依托单位:
Leadership, Planning and Evaluation
-
批准号:10270216
-
项目类别:
-
资助金额:$27.01万
-
财政年份:1997
-
负责人:David A Tuveson
-
依托单位:
Administration
-
批准号:10270209
-
项目类别:
-
资助金额:$20.44万
-
财政年份:1997
-
负责人:David A Tuveson
-
依托单位:
Developmental Funds
-
批准号:10675624
-
项目类别:
-
资助金额:$82.16万
-
财政年份:1997
-
负责人:David A Tuveson
-
依托单位:
CSHL Cancer Center Support Grant
-
批准号:10675613
-
项目类别:
-
资助金额:$449.55万
-
财政年份:1997
-
负责人:David A Tuveson
-
依托单位:
海外基金